Exelixis
EXEL
#2073
Rank
HK$59.63 B
Marketcap
HK$209.06
Share price
-2.83%
Change (1 day)
25.22%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Number of shares outstanding for Exelixis (EXEL)

Number of shares outstanding as of September 2024 : 289,216,000

According to Exelixis's latest financial reports and stock price the company's current number of shares outstanding is 289,216,000. At the end of 2024 the company had 289,216,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Exelixis from 2000 to 2024

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20240.28 B-6.25%
20230.30 B-4.57%
20220.32 B1.79%
20210.31 B2.19%
20200.31 B2.11%
20190.30 B1.65%
20180.29 B1.14%
20170.29 B2.73%
20160.28 B26.69%
20150.22 B16.32%
20140.19 B6.05%
20130.18 B10.83%
20120.16 B28.81%
20110.12 B18.84%
20100.10 B1.24%
20090.10 B1.69%
20080.10 B7.1%
200798.55 M17.07%
200684.17 M5.83%
200579.54 M10.21%
200472.17 M1.66%
200370.99 M25.69%
200256.48 M18.29%
200147.75 M15.96%
200041.17 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
2,034,500,000 603.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
2,497,600,000 763.58%๐Ÿ‡ซ๐Ÿ‡ท France
2,535,649,470 776.73%๐Ÿ‡บ๐Ÿ‡ธ USA
2,027,000,000 600.86%๐Ÿ‡บ๐Ÿ‡ธ USA
537,000,000 85.67%๐Ÿ‡บ๐Ÿ‡ธ USA
2,406,800,000 732.18%๐Ÿ‡บ๐Ÿ‡ธ USA
5,666,000,000 1,859.09%๐Ÿ‡บ๐Ÿ‡ธ USA
5,818,416-97.99%๐Ÿ‡บ๐Ÿ‡ธ USA
34,618,000-88.03%๐Ÿ‡บ๐Ÿ‡ธ USA